Albert D. Dyrness

Director, Outlook Therapeutics, Inc.

Companies

Hyperliquid StrategiesBoard member Dec 23, 2025 to now¹
Sonnet BioTherapeutics Holdings, Inc.Board member Apr 3, 2020 to now²
Outlook Therapeutics, Inc.Board member May 12, 2016 to Oct 30, 2017³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHyperliquid Strategies, Board member
2
SEC EDGARSonnet BioTherapeutics Holdings, Inc., Board member
3
SEC EDGAROutlook Therapeutics, Inc., Board member